Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Vague or promotional

Rules 1.1.0 · as of 14 Sep 2026

Quote

Vague or promotional

“Large-scale trials of Neuromodulation for non-psychiatric indications will start enrolling. Expect Parkinson’s Disease, dystonia, TD, weight loss, and pain associated with general medical conditions to enroll, if not conclude enrollment.”
· Ten 2026 Predictions on Which to Hang Your Hat. · substack post

Item 5 of the 2026 predictions list: large neuromodulation trials in non-psychiatric indications (Parkinson's disease, dystonia, tardive dyskinesia, weight loss, pain in general medical conditions) will begin enrolling in 2026.

No entity, observable event, benchmark or threshold can be written from the text and its immediate context. Slogans ('game changer', 'once-in-a-lifetime opportunity', 'favourite stock') and quantifiers with no countable set ('more', 'first', 'all') without a defined set.